Our aim was to investigate the durability of bictegravir/emtricitabine/tenofovir alafenamide (B/F/ TAF) regimen and its safety in a real-life setting.
Safety and durability of treatment with bictegravir/emtricitabine/tenofovir alafenamide in a real-life cohort
G. F. Pellicano';
2025-01-01
Abstract
Our aim was to investigate the durability of bictegravir/emtricitabine/tenofovir alafenamide (B/F/ TAF) regimen and its safety in a real-life setting.File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
